A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy - Wikidata - awgldk - TriplyDB

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

http://www.wikidata.org/entity/Q33645564

about

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters Recent Advances in Lentiviral Vaccines for HIV-1 Infection Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions Should we treat acute HIV infection?Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?The evolution of poxvirus vaccines Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Immunologic strategies for HIV-1 remission and eradication.AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.Immune interventions in HIV infection.A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy A therapeutic dendritic cell-based vaccine for HIV-1 infection.HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo Immunotherapy with an HIV-DNA Vaccine in Children and Adults.Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.Directing dendritic cell immunotherapy towards successful cancer treatment.Innate immune recognition of poxviral vaccine vectors.Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?Therapeutic vaccines against HIV infection.Dendritic cell dysregulation during HIV-1 infection.Dendritic cell based vaccines for HIV infection: the way ahead.Future considerations for dendritic cell immunotherapy against chronic viral infections.Toward a cure for HIV--Seeking effective therapeutic vaccine strategies.New challenges in therapeutic vaccines against HIV infection.Novel immunological strategies for HIV-1 eradication Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity.An immunoregulatory role of dendritic cell-derived exosomes versus HIV-1 infection: take it easy but be warned The dendritic cell: the general of the army.Dendritic cell immunotherapy.Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection.Immune Interventions to Eliminate the HIV Reservoir.Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer

P2860

Q24615872-E1B812C5-0A0C-4500-8BCC-50C82F2CFDCE Q26742169-6D7C80A2-20BB-446E-A120-A9708E2673BF Q26775082-7E357E9A-FA58-4423-A886-D692068A6D1A Q26777442-3AF0CBF7-FD1B-4E5A-A0D1-4A5B2904F005 Q26826523-D72BB242-1642-4384-8906-79DD525B7D99 Q26865388-5E742215-0F3E-4EB9-85D3-735AD946F2C0 Q26995905-F095280B-AA93-4C53-A30C-92AA5B21817F Q28070121-F7FADBE8-F20B-4124-B5A8-086D446BF55C Q33819656-5F719BAD-3AC1-4AD7-870F-F92F3F372FD5 Q33896523-3E76DE92-9E93-48A5-AA9B-2FE75754EBFD Q34047774-91DBC8A2-CBB4-41F5-B45C-0C56219EE67D Q34351326-5F08BAD0-FD82-4BC7-A238-8A8547D8D3B2 Q34646987-66587520-3817-423A-AC34-13775BCDD116 Q34749218-030543EA-DC1F-47DC-A6C5-B9EBCE8DD18E Q34764392-CCCCFC53-E6FB-403E-87AD-58126032EC74 Q35029956-33ECA48E-0245-40EF-B00E-5C10B32BD9C8 Q35826642-8D4BD81F-ABAD-4A14-8839-9920836F2DB6 Q36813547-8CE3907F-5AB1-4F74-B9D7-411A45DA9520 Q37014116-A44A829E-5E9C-4F4A-BDC8-B91C7DDE7746 Q37754014-ECA3F755-773D-44D3-A9C7-5DAF7C7312C1 Q37944321-19CA15CA-67CD-43BE-8CDD-EC9DC7D0C695 Q37945301-5AD8BBAB-4A5F-43EE-9215-BA98716B5147 Q38013505-7F5826AC-209D-4FF1-9487-5B10FD47A189 Q38114911-89319F8A-8AC3-41F1-BC6C-BF4708EA21EF Q38126373-3EB0FF81-4F43-4729-8E11-9C4CC877AD8C Q38204769-F4C6E4E4-A967-4093-8302-861A971AC9EA Q38626469-694C0E31-B706-4367-9AED-A4CE57486381 Q38692205-9AFE17EF-5D9C-4E4A-A577-25659DEA3FF5 Q38915896-33A6A220-C785-4518-AFCA-675817BB2D18 Q39547016-38A685A5-BD09-431E-BAB8-9B85C7E2F2C3 Q39550595-F3ECE0CC-B826-4EF2-A56E-8F7390F6FC09 Q40277992-45A3766C-271A-465A-9CAF-DE8F710F84C7 Q41217724-FF32F529-7C63-4A10-AA9A-8B2495A1D2F7 Q42359045-8BB87986-55DE-4E3E-BFFF-6D2033B527C0 Q42739326-BDD1CE03-1864-4475-B2B8-6C1BF1A68E75 Q44483910-71C8CEFD-9F33-4CED-A54A-90097872A5E3 Q44606374-286F3869-3B61-40C6-AE75-6592C808E057 Q47600062-7DE55B3D-D4FF-42BF-BD15-9171E940B3C5 Q58786746-80A3E1B4-C9F1-4808-9CBF-A0B4AD9332FB

P2860

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

http://www.wikidata.org/entity/Q33645564

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@ast

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@en

type

label

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@ast

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@en

prefLabel

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@ast

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@en

P1433

Q33645564-3FE3F7DD-1D63-47BF-9ADE-FE4D16866780

P1476

Q33645564-410D440D-CA5B-459F-8F49-1AFB6EA860D1

P2093

Q33645564-03610E8F-E208-4A65-91E2-748AAEFA0B0C

Q33645564-0B811EF7-0457-4698-AD6B-3D503202345D

Q33645564-0D61E4F1-9287-4CB3-AD4F-56AC7ADEB2C5

Q33645564-3758C761-4BEA-4FD9-BBC1-9F82E261A4B5

Q33645564-40D11A32-90AD-429A-8CA0-F2DA945ADC97

Q33645564-46EB510D-88B4-4F00-9019-386112253F92

Q33645564-499A341A-5C33-4E09-8460-4EBF3A1B043F

Q33645564-5FE09FD9-031D-44CE-AD2E-5CDE12C7C4B8

Q33645564-6CD65ECF-2E9F-4F79-8291-AA07436F82E5

Q33645564-926FF09D-AD24-44BC-867C-A4CBA12A9B78

P2860

Q33645564-0BABE9C2-E311-485E-A1FC-4066875D7238

Q33645564-0E68AFBD-9563-476A-ABBE-EEEBEA29221D

Q33645564-17F08227-9B85-464F-B01D-B21DE6046A9A

Q33645564-1B22CD78-B371-4583-A0BF-E41F77B87AEA

Q33645564-1BFCF9CF-D42E-4E1C-B6FD-C111DE721DA8

Q33645564-1DD7C5E1-FECC-4864-B6BA-F55EBA416B0B

Q33645564-3A45A0E0-0B8C-4A92-8348-35A5FAD46589

Q33645564-3B99AC55-A3CA-4309-89A8-7ED9B8789A5B

Q33645564-461D08A2-8977-49FD-A40D-01FD6E82957C

Q33645564-535A34B7-0FF4-4D26-A857-8530CD4607E6

P304

Q33645564-BBC12059-1B81-4E02-AFB3-4582F862F6E0

P31

Q33645564-980740A7-94CD-4278-880A-D322AF6F2F3C

P356

Q33645564-72EE1075-F7BE-4C59-AC47-1D258329092D

P407

Q33645564-EFE8E34A-2633-4ABC-A3C9-0F22BB9C2547

P433

Q33645564-2287B49D-6033-4AE5-B73B-CD5B7A90BFB4

P478

Q33645564-F0B6763E-A2AA-46A7-9399-EDBC9D233D0A

P577

Q33645564-24D115D3-6FD3-4616-AA9A-A588EE1729D3

P5875

Q33645564-3906E201-9E3A-4FFA-B563-47BC6AEC3BE1

P698

Q33645564-27158B09-FC33-4DD4-9F37-F1C22D0F8073

P921

Q33645564-56240DB0-E5E6-4D20-9DDB-13EF3A2B70BB

P932

Q33645564-C214D6A5-D448-41DC-97CE-C8B77114968E

P356

J.VACCINE.2009.05.016

P1433

P1476

A randomized therapeutic vacci ...... ents on antiretroviral therapy

@en

P2093

AIDS Clinical Trials Group A5130 team

http://www.w3.org/2001/XMLSchema#string

Ann Marshak

http://www.w3.org/2001/XMLSchema#string

Barbara Schock

http://www.w3.org/2001/XMLSchema#string

David O'Neill

http://www.w3.org/2001/XMLSchema#string

Donna Mildvan

http://www.w3.org/2001/XMLSchema#string

Elizabeth Adams

http://www.w3.org/2001/XMLSchema#string

Ellen S Chan

http://www.w3.org/2001/XMLSchema#string

Janet Shopis

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Jacobson

http://www.w3.org/2001/XMLSchema#string

Lawrence Fox

http://www.w3.org/2001/XMLSchema#string

P2860

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy

Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.

Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

P304

6088-6094

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2009.05.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24435486

http://www.w3.org/2001/XMLSchema#string

P698

19450647

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2820102

http://www.w3.org/2001/XMLSchema#string